Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

Clinical trial NCT00570752 · COMPLETED

Trial details

NCT number: NCT00570752
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Vascular Diseases

Start date: 2008-12-01
Primary completion: 2010-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.